Now showing items 1-1 of 1
S100β as a serum marker in endocrine resistant breast cancer
(Springer Nature, 2017-04-12)
Background: Endocrine therapy is standard treatment for estrogen receptor (ER)-positive breast cancer. However, its efficacy is limited by intrinsic and acquired resistance. Here the potential of S100 beta as a biomarker ...